These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38367817)
1. MG53: A new protagonist in the precise treatment of cardiomyopathies. Zhao Q; Zhang Q; Zhao X; Tian Z; Sun M; He L Biochem Pharmacol; 2024 Apr; 222():116057. PubMed ID: 38367817 [TBL] [Abstract][Full Text] [Related]
2. Lack of MG53 in human heart precludes utility as a biomarker of myocardial injury or endogenous cardioprotective factor. Lemckert FA; Bournazos A; Eckert DM; Kenzler M; Hawkes JM; Butler TL; Ceely B; North KN; Winlaw DS; Egan JR; Cooper ST Cardiovasc Res; 2016 May; 110(2):178-87. PubMed ID: 26790476 [TBL] [Abstract][Full Text] [Related]
3. The Pivotal Role of Mitsugumin 53 in Cardiovascular Diseases. Jiang W; Liu M; Gu C; Ma H Cardiovasc Toxicol; 2021 Jan; 21(1):2-11. PubMed ID: 33006052 [TBL] [Abstract][Full Text] [Related]
4. MG53 E3 Ligase-Dead Mutant Protects Diabetic Hearts From Acute Ischemic/Reperfusion Injury and Ameliorates Diet-Induced Cardiometabolic Damage. Feng H; Shen H; Robeson MJ; Wu YH; Wu HK; Chen GJ; Zhang S; Xie P; Jin L; He Y; Wang Y; Lv F; Hu X; Zhang Y; Xiao RP Diabetes; 2022 Feb; 71(2):298-314. PubMed ID: 34844991 [TBL] [Abstract][Full Text] [Related]
5. MG53: Biological Function and Potential as a Therapeutic Target. Zhang Y; Wu HK; Lv F; Xiao RP Mol Pharmacol; 2017 Sep; 92(3):211-218. PubMed ID: 28432201 [TBL] [Abstract][Full Text] [Related]
6. Glucose-Sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic Homeostasis. Wu HK; Zhang Y; Cao CM; Hu X; Fang M; Yao Y; Jin L; Chen G; Jiang P; Zhang S; Song R; Peng W; Liu F; Guo J; Tang L; He Y; Shan D; Huang J; Zhou Z; Wang DW; Lv F; Xiao RP Circulation; 2019 Feb; 139(7):901-914. PubMed ID: 30586741 [TBL] [Abstract][Full Text] [Related]
7. Advances in the Study of MG53 in Cardiovascular Disease. Liu SM; Zhao Q; Li WJ; Zhao JQ Int J Gen Med; 2023; 16():6073-6082. PubMed ID: 38152078 [TBL] [Abstract][Full Text] [Related]
8. Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy. Weisleder N; Takizawa N; Lin P; Wang X; Cao C; Zhang Y; Tan T; Ferrante C; Zhu H; Chen PJ; Yan R; Sterling M; Zhao X; Hwang M; Takeshima M; Cai C; Cheng H; Takeshima H; Xiao RP; Ma J Sci Transl Med; 2012 Jun; 4(139):139ra85. PubMed ID: 22723464 [TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant human MG53 protein on tourniquet-induced ischemia-reperfusion injury in rat muscle. Corona BT; Garg K; Roe JL; Zhu H; Park KH; Ma J; Walters TJ Muscle Nerve; 2014 Jun; 49(6):919-21. PubMed ID: 24395153 [TBL] [Abstract][Full Text] [Related]
10. MG53: A potential therapeutic target for kidney disease. Ke B; Shen W; Song J; Fang X Pharmacol Res Perspect; 2023 Feb; 11(1):e01049. PubMed ID: 36583464 [TBL] [Abstract][Full Text] [Related]
11. Cardiac effects and clinical applications of MG53. Zhong W; Benissan-Messan DZ; Ma J; Cai C; Lee PHU Cell Biosci; 2021 Jun; 11(1):115. PubMed ID: 34183055 [TBL] [Abstract][Full Text] [Related]
12. Cardiac Ischemic Preconditioning Promotes MG53 Secretion Through H Shan D; Guo S; Wu HK; Lv F; Jin L; Zhang M; Xie P; Wang Y; Song Y; Wu F; Lan F; Hu X; Cao CM; Zhang Y; Xiao RP Circulation; 2020 Sep; 142(11):1077-1091. PubMed ID: 32677469 [TBL] [Abstract][Full Text] [Related]
13. Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury. Liu J; Zhu H; Zheng Y; Xu Z; Li L; Tan T; Park KH; Hou J; Zhang C; Li D; Li R; Liu Z; Weisleder N; Zhu D; Lin P; Ma J J Mol Cell Cardiol; 2015 Mar; 80():10-19. PubMed ID: 25533937 [TBL] [Abstract][Full Text] [Related]
14. Serum MG53/TRIM72 Is Associated With the Presence and Severity of Coronary Artery Disease and Acute Myocardial Infarction. Xie H; Wang Y; Zhu T; Feng S; Yan Z; Zhu Z; Ni J; Ni J; Du R; Zhu J; Ding F; Liu S; Han H; Zhang H; Zhao J; Zhang R; Quan W; Yan X Front Physiol; 2020; 11():617845. PubMed ID: 33391037 [No Abstract] [Full Text] [Related]
15. MG53 is a double-edged sword for human diseases. Zhang Y; Wu HK; Lv FX; Xiao RP Sheng Li Xue Bao; 2016 Aug; 68(4):505-16. PubMed ID: 27546510 [TBL] [Abstract][Full Text] [Related]
16. MG53 inhibits angiogenesis through regulating focal adhesion kinase signalling. Dong J; Zhou H; Li Y; Li R; Chen N; Zheng Y; Deng X; Luo M; Wu J; Wang L J Cell Mol Med; 2021 Aug; 25(15):7462-7471. PubMed ID: 34240802 [TBL] [Abstract][Full Text] [Related]
17. Protective role of MG53 against ischemia/reperfusion injury on multiple organs: A narrative review. Xu B; Wang C; Chen H; Zhang L; Gong L; Zhong L; Yang J Front Physiol; 2022; 13():1018971. PubMed ID: 36479346 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α. Liu F; Song R; Feng Y; Guo J; Chen Y; Zhang Y; Chen T; Wang Y; Huang Y; Li CY; Cao C; Zhang Y; Hu X; Xiao RP Circulation; 2015 Mar; 131(9):795-804. PubMed ID: 25637627 [TBL] [Abstract][Full Text] [Related]
19. Mitsugumin 53 attenuates the activity of sarcoplasmic reticulum Ca(2+)-ATPase 1a (SERCA1a) in skeletal muscle. Lee KJ; Park CS; Woo JS; Kim DH; Ma J; Lee EH Biochem Biophys Res Commun; 2012 Nov; 428(3):383-8. PubMed ID: 23103543 [TBL] [Abstract][Full Text] [Related]
20. Mitsugumin 53 (MG53) facilitates vesicle trafficking in striated muscle to contribute to cell membrane repair. Weisleder N; Takeshima H; Ma J Commun Integr Biol; 2009 May; 2(3):225-6. PubMed ID: 19641737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]